Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC - Wang, Qian; Guo, Yicheng; Mellis, Ian A.; Wu, Madeline; Mohri, Hiroshi; Gherasim, Carmen; Valdez, Riccardo; Purpura, Lawrence J.; Yin, Michael T.; Gordon, Aubree; Ho, David D. (Cell reports (Cambridge), 2025)
Keywords: ACE2 inhibition; Angiotensin-Converting Enzyme 2 - immunology; Angiotensin-Converting Enzyme 2 - metabolism; Animals; Antibodies, Monoclonal - immunology; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; antibody evasion; COVID-19 - immunology; COVID-19 - virology; CP: Immunology; CP: Microbiology; Humans; JN.1 subvariants; KP.3.1.1; monoclonal antibodies; mRNA vaccines; Mutation; Neutralization Tests; SARS-CoV-2; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; serum neutralization; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; XEC; CP: Immunology; ACE2 inhibition; SARS-CoV-2; XEC; CP: Microbiology; mRNA vaccines; JN.1 subvariants; antibody evasion; serum neutralization; KP.3.1.1; monoclonal antibodies